Australian Journal of Chemistry 63 (11) pp.1503
- 1504
Metal-based Drugs
All the contributions in this Research Front on metal-based drugs are concerned with organometallic compounds and the papers reflect the diversity of the types of compounds being studied.
Published 11 November 2010
A Bioorganometallic Chemistry Overview: From Cytochrome P450 Enzyme Metabolism of Organotin Compounds to Organorhodium-Hydroxytamoxifen Complexes with Potential Anti-Cancer Properties; A 37 Year Perspective at the Interface of Organometallic Chemistry and Biology
Richard H. Fish
Australian Journal of Chemistry 63 (11) pp.1505
- 1513
Published 11 November 2010
Novel Achiral Aryl-Substituted Vanadocenes: Synthesisand Preliminary Cytotoxicity Studies
Brendan Gleeson , Anthony Deally , Helge Müller-Bunz , Siddappa Patil , Matthias Tacke
Australian Journal of Chemistry 63 (11) pp.1514
- 1520
Published 11 November 2010
Influence of the Arene Ligand and the Leaving Group on the Anticancer Activity of (Thio)maltol Ruthenium(II)–(η6-Arene) Complexes
Muhammad Hanif , Patricia Schaaf , Wolfgang Kandioller , Michaela Hejl , Michael A. Jakupec , Alexander Roller , Bernhard K. Keppler , Christian G. Hartinger
Australian Journal of Chemistry 63 (11) pp.1521
- 1528
Published 11 November 2010
Synthesis, Characterization and Anticancer Activity of Porphyrin-Containing Organometallic Cubes
Nicolas P. E. Barry , Olivier Zava , Paul J. Dyson , Bruno Therrien
Australian Journal of Chemistry 63 (11) pp.1529
- 1537